# RenovoRx, Inc.: Form 8-K, filed Jun 9, 2022

- Company: [RenovoRx, Inc.](/companies/rnxt.md) (CIK 1574094)
- Form: 8-K
- Filed: 2022-06-09
- Accepted by EDGAR: Jun 9, 2022, 17:09 ET
- Period: 2022-06-09
- Accession: 0001493152-22-016328
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1574094/000149315222016328/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574094/000149315222016328/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574094/000149315222016328/form8-k.htm

Filed Jun 9, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-016328. Last ingested by Listed: Nov 6, 2026, 17:30 ET. No prices; not investment advice.
